Smithkline Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SMITHKLINE, and what generic and branded alternatives to SMITHKLINE drugs are available?
SMITHKLINE has three approved drugs.
Summary for Smithkline
US Patents: | 0 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 3 |
Patent Litigation for Smithkline: | See patent lawsuits for Smithkline |
Drugs and US Patents for Smithkline
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-002 | Dec 24, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-002 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-001 | Dec 24, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Smithkline
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | 4,760,075 | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | 4,375,547 | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | 4,382,090 | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | 4,375,547 | ⤷ Try a Trial |
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-002 | Dec 24, 1991 | 4,420,639*PED | ⤷ Try a Trial |
Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-001 | Dec 24, 1991 | 4,420,639*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SMITHKLINE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Oral Solution | 15 mg/mL | ➤ Subscribe | 2008-05-14 |
Similar Applicant Names
Here is a list of applicants with similar names.